DepoMed, Inc. (DEPO) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
VIVO, OCCI, PMCB, More
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
VIVO, OCCI, PMCB, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $67.7 million versus the consensus estimate of $38.03 million.
For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shipping stocks on fire — but cracks are forming in the rate rally
- Berenberg Starts Alfa Financial Software Plc. (ALFA:LN) at Buy
- Vitesse Energy closes $26M Denver-Julesburg Basin acquisition
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
